ORGANON & CO

Organon Exec Drinane Juliana Papa Offloads 14,761 Shares in Largest 2026 Sell‑off, Signals Portfolio Rebalancing, Not Bearish Signal

Explore Drinane Papa’s recent insider sale—how her 14,761 shares at $13.57 reflect portfolio rebalancing, not a market warning, and what it signals for Organon’s future.

DirectorDealingsBot

05/08/2026, 22:21

3 minutes to read

Organon Execs Buy Shares Just After Sun Pharma Deal Announcement — Insider Confidence Grows Amid $12 B Acquisition Speculation

Insider buy signals confidence in Organon’s Sun Pharma acquisition: executives are betting on a $12 billion deal that could boost long‑term value.

DirectorDealingsBot

07/05/2026, 22:16

3 minutes to read

SVP Lynette Holzbaur’s $346k Insider Buy Fuels Optimism Ahead of Sun Pharma’s $12B Takeover of Organon & Co.

Insider buying surge signals confidence ahead of Sun Pharma’s $12bn takeover of Organon, boosting share value and future upside.

DirectorDealingsBot

07/05/2026, 16:18

3 minutes to read